BIOMAT Database Logo BIOMAT Database Logo

Evaluation of surgical response in renovascular hypertension using angiotensin II blockade. 1978

J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich

The mechanisms involved in residual or recurrent hypertension following operation to correct renal artery stenosis were studied in 10 patients by performing angiotensin II blockade with Saralasin (Sarcosine, alanine, angiotensin II) before and after operation. Peripheral renin and renal vein renin determinations, angiography, and renography were done as well. The limitations of renin determinations are cited and the application of angiotensin II blockade as a specific method of detecting renin-dependent hypertension before and after operation are presented. Saralasin infusion under the controlled conditions of our study proved to be a sensitive method for detection of renin-dependent hypertension. The results of Saralasin infusion correlated closely with peripheral and renal vein renin determinations. Thus angiotensin II blockade before and after operation may supercede more invasive and less specific diagnostic methods.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate

Related Publications

J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Detection of renovascular hypertension with angiotensin II blockade.
March 1977, Annals of internal medicine,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
[Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
December 1978, La Nouvelle presse medicale,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Predictive value of angiotensin II blockade with (sarcosine-1, threonine-8) angiotensin II in renovascular hypertension.
January 1983, The Journal of urology,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
June 1977, British journal of urology,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Renal actions of angiotensin II in renovascular hypertension.
August 1987, Canadian journal of physiology and pharmacology,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
December 1979, Clinical science (London, England : 1979),
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Renovascular hypertension in rats immunized with angiotensin II.
February 1972, Circulation research,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Predictive value of angiotensin II antagonists in renovascular hypertension.
January 1983, JAMA,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Angiotensin II type 1 receptor blockade restores nitric oxide-dependent renal vascular responses in renovascular hypertension.
September 2002, Journal of cardiovascular pharmacology,
J A Buda, and L Baer, and S P Arora, and J Z Parra-Carrillo, and I Radichevich
Prostaglandin E2, renin and angiotensin II in renovascular hypertension.
August 1984, Journal of hypertension,
Copied contents to your clipboard!